Twitxy Saved

Lexi Rovner

Verified account This account is verified. Learn more

@lexrovner

co-founder & ceo @64xbio | @ycombinator S18 | prev @ucberkeley @yale @geochurch lab @wyssinstitute @harvard | musician, runner, skier
San Francisco, CA 64xbio.com Joined October 2012
2.2K Following 2.8K Followers 597 Posts

Latest posts 5

Lexi Rovner Verified account @lexrovner
We’re launching LV Apex Suite today, our second Apex Suite after AAV. Each new modality adds data on what’s shared, what’s different, and how to engineer production systems in an integrated way. That’s tied to a core view at @64xbio:

Cell lines, reagents, and process aren't separate levers, they're interdependent parts of a single production system. If we want better productivity, quality, and scalability, we need to understand and engineer that system more holistically.

That’s what we’re building toward with CellMap: data-rich experimental maps of production biology that we can learn from computationally, to guide the design of better cell lines and reagents. Biologics are next, and existing suites will keep expanding with additional tools.

With this, we’re also growing our commercial and ops teams. If you’re excited about building next gen biomanufacturing tools, DM me.

Incredibly proud of the team today for all the work behind this launch. Much more to come.
64x Bio Verified account @64xbio Jun 29
New product launch: Today we’re launching LV Apex Suite, a new product suite for lentiviral vector production.

This marks 64x Bio’s expansion from AAV into LV — and another step in translating our CellMap-driven VectorSelect platform across new modalities.

LV Apex Suite begins with a high yield engineered HEK293T suspension cell line for transient LV production, with stable systems and additional production-enabling technologies in development.

More broadly, this launch reflects where 64x Bio is headed: expanding CellMap as a data foundation for production biology, and learning from those data computationally to iteratively guide development of better cell lines, reagents, and production systems for viral vectors — and soon, biologics.

To learn more about LV Apex Suite, read our press release below and visit 64xbio.com/lvapexsuite.

Press release: 64xbio.com/articles/64x-b…
View quoted post on X
7 replies 10 reposts 40 likes 21K views View on X
Lexi Rovner Verified account @lexrovner
Headed to #BIO2026 next week. Lots of exciting things happening at @64xbio right now and we’re also expanding our commercial and ops teams. DM me to meet up, I’m excited to see everyone there.
64x Bio Verified account @64xbio Jun 21
We'll be in San Diego next week for #BIO2026! The 64x team will be on the ground and @lexrovner is on two panels on advanced medicines, across AI and manufacturing. If you'll be there, we'd love to meet — reach out to us in the BIO partnering portal or at bd@64xbio.com
View quoted post on X
0 replies 0 reposts 19 likes 1.4K views View on X
Lexi Rovner Verified account @lexrovner
Go Beth!
Beth Turner Verified account @ElizabethTurner Dec 4, 2025
Today I’m launching @Valkyrie_vc - a $45M early-stage fund investing in AI, infrastructure, and critical industries.

Grateful to the founders, partners, and friends I’ve worked with along the way. You’ve truly shaped how I invest and why I built Valkyrie.

To the founders: Valkyrie was built for you. To partner with you. To build what matters. This is our new frontier. Let’s build it.

Thank you to @_pheebini at @Forbes who captured the story → forbes.com/sites/phoebeli…
View quoted post on X
Lexi Rovner Verified account @lexrovner
I’m really excited to see what happens at the interface of biotech and AI over the next few years. The scale and type of data generation will be key. Gleb & crew have been building something really unique and special here. Give it a read: @glebkuz @PierceOgdenJ @slofgren
Gleb Kuznetsov Verified account @glebkuz Sep 29, 2025
We're stil writing the @ManifoldBio story, but @ElliotHershberg just dropped a fantastic piece capturing the journey so far on his blog Century of Biology.
View quoted post on X
1 replies 3 reposts 8 likes 1.1K views View on X
Lexi Rovner Verified account @lexrovner
I joined @iamjulieo, @KateRochlin, and @bruna_paulsen last week at BIO, to talk about biomanufacturing for advanced medicines -- such a critical piece of making this field work. Big thanks to @MadridMarinna for moderating and giving me the opportunity to spotlight the work we've been doing to help tackle these challenges through our platform and new product line, AAV Apex Suite.

Of course, none of this would be possible without the incredible team @64xbio -- they're the ones doing the real heavy lifting.